Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With Ticagrelor
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.
Also called NCT01869309
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 400 participants
- Sponsor
- Registry
-
NCT01869309
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Unknown status
Technical summary
Registry record NCT01869309. Randomized; no masking; primary purpose treatment. Start 2014-01 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With Ticagrelor
- Acronym
- HEIGHTEN
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Prasugrel
- Intervention (Drug)
- Ticagrelor
- Lead sponsor
- LifeBridge Health
- Collaborator
- AstraZeneca
Record details
- Record id
cardio:ct-nct01869309- Content hash
3aaa2aa23f8ff49f9690f55d137d9ae65fbd651b5fe960413be1972b59256c0c